Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

38
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
38

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gonadal Sex and Sex-Chromosome Complement Interact to Affect Ethanol Consumption in Adolescent Four Core Genotypes Mice.

Brain sciences·2026
Same author

Characterizing Nature Videos for an Attention Placebo Control for MBSR: The Development of Nature-Based Stress Reduction (NBSR).

Mindfulness·2026
Same author

A shared genetic regulator of metabolism and addiction-related behavior in mice and humans.

bioRxiv : the preprint server for biology·2026
Same author

Inactivation of NMDAR and CaMKII signaling within the prelimbic cortex blocks incubated cocaine- and sucrose-craving.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Cross-Sensitization between Binge Eating and Binge Drinking in a Novel C57BL/6NJ Murine Model of Disease Comorbidity Requires PDE4B Activation.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2025
Same author

Financial Incentives for Substance Abstinence: A Systematic Review and Meta-analysis.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2025

Related Experiment Video

Updated: Jun 4, 2025

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
08:27

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Published on: March 11, 2020

6.1K

Dysbindin-1 Mutation Alters Prefrontal Cortex Extracellular Glutamate and Dopamine In Vivo.

Karen K Szumlinski1,2, Michael C Datko1, Kevin D Lominac1

  • 1Department of Psychological and Brain Sciences, University of California Santa Barbara, Santa Barbara, CA 93106, USA.

International Journal of Molecular Sciences
|December 17, 2024
PubMed
Summary

Schizophrenia risk is linked to the DTNBP1 gene. This study shows DTNBP1 mutations impair glutamate and dopamine release in the prefrontal cortex, potentially explaining cognitive deficits.

Keywords:
NMDA receptorsdysbindin-1extracellular dopamineextracellular glutamatein vivo microdialysisprefrontal cortex

More Related Videos

Developing a Rat Model for Bipolar Disorder
04:44

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

204
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.0K

Related Experiment Videos

Last Updated: Jun 4, 2025

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
08:27

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Published on: March 11, 2020

6.1K
Developing a Rat Model for Bipolar Disorder
04:44

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

204
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.0K

Area of Science:

  • Neuroscience
  • Genetics
  • Psychiatry

Background:

  • Schizophrenia is linked to DTNBP1 gene variations, potentially causing cognitive impairments.
  • Cognitive symptoms involve prefrontal cortex (PFC) glutamate and dopamine signaling anomalies.
  • DTNBP1 mutations in mice cause memory deficits linked to glutamate release and NMDA receptor dysfunction.

Purpose of the Study:

  • Investigate the impact of DTNBP1 mutations on in vivo glutamate and dopamine release in the PFC.
  • Examine NMDA receptor-evoked neurotransmitter release in DTNBP1 mutant mice.
  • Assess basal extracellular neurotransmitter levels in the PFC of mutant mice.

Main Methods:

  • In vivo microdialysis in the prefrontal cortex of wild-type, heterozygous, and mutant mice.
  • Stimulation with high K+ and NMDA to evoke neurotransmitter release.
  • No net-flux microdialysis to measure basal extracellular neurotransmitter content.

Main Results:

  • High K+ and NMDA failed to evoke dopamine and glutamate release in DTNBP1 mutants.
  • Heterozygous mice showed blunted K+-evoked dopamine release.
  • Elevated basal extracellular glutamate and dopamine levels were observed in mutant and heterozygous mice.

Conclusions:

  • DTNBP1 mutations disrupt evoked dopamine and glutamate release in the PFC.
  • Provides in vivo evidence for impaired NMDA receptor function in the PFC.
  • Abnormally elevated basal neurotransmitter levels may contribute to cognitive deficits in schizophrenia.